Issue of h shares under general mandate
Filed with HKEX · Stock code 2410 · · 8 pages · English
Summary by 6ix AI
This filing is an announcement regarding the issue of H shares under a general mandate by TYK Medicines, Inc.. The proceeds from this subscription are intended to support clinical trials and general corporate purposes. Completion of the subscription is subject to various conditions, and shareholders are advised to exercise caution when dealing in the shares.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from TYK Medicines
- Voluntary announcement - business update on commercialisation of core product Kardorisso (TY-9591)
- Update on license and collaboration with qilu and settlement of legal proceedings
- Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2026
- Articles of association
- Poll results of 2026 second extraordinary general meeting held on October 16, 2026
Follow TYK Medicines into a list and get an email when it puts out news.
Follow TYK Medicines